In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfenex Inc.

www.pfenex.com

Latest From Pfenex Inc.

Last Year’s Winners Build On Successes

Firms that achieved recognition at last year’s Global Generics & Biosimilars Awards have continued to build on that success in the months since.

Generic Drugs Biosimilars

Alvogen And Pfenex Have Teriparatide Filing Accepted By EMA

The EMA has formally accepted for filing Alvogen and Pfenex’ centralized marketing authorization application for a biosimilar rival to Lilly’s Forsteo teriparatide blockbuster.

 


Europe Biosimilars

Formycon Plans Ranibizumab Filings With Ustekinumab And Aflibercept In The Wings

Formycon will follow a US filing for ranibizumab before the end of this year with a European submission early in 2020 as it continues work on biosimilar ustekinumab and aflibercept.
Biosimilars Ophthalmic

Pfenex Pitches Teriparatide Pen Against Lilly's Forteo as Partner Alvogen Files In Europe

Alvogen is conducting a study directing comparing its teriparatide delivery device with that of Lilly’s Forteo in a bid to be substitutable in the US for Pfizer’s original. The firm’s partner, Alvogen, has just filed the osteoporosis drug under Europe’s centralized procedure.

 


Value-Added Medicines United States
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Generic Drugs
    • Vaccines
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfenex Inc.
  • Senior Management
  • Evert (Eef) Schimmelpennink, Pres. & CEO
    Susan Knudson, CFO
    Patrick K Lucy, CBO
    Hubert C Chen, MD, CMO & CSO
  • Contact Info
  • Pfenex Inc.
    Phone: (858) 352-4400
    10790 Roselle St.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register